| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 04/25/1996 | WO1996011933A1 Fused pyrrolocarbazoles |
| 04/25/1996 | CA2202480A1 Porphyrin labeling of polynucleotides |
| 04/24/1996 | EP0707591A1 Methylphosphonic acid ester, process for preparing the same and its use |
| 04/24/1996 | EP0707590A1 Dideoxyfructonucleotides and deoxyfructonucleotides as dna polymerase substrates |
| 04/24/1996 | EP0707481A1 L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents |
| 04/24/1996 | EP0533825B1 Ether lipid-nucleoside covalent conjugates |
| 04/24/1996 | CN1120936A Process for the production of a pharmaceutical composition comprising an ATP anologue |
| 04/23/1996 | US5510469 2-acyloxy-4-morpholinyl anthracyclines |
| 04/23/1996 | US5510372 For treating or preventing insect or worm infestations in animals |
| 04/23/1996 | US5510336 2-halo-2'-deoxyadenosine treatment for histiocytosis |
| 04/23/1996 | US5510270 Generating pattern of light and dark areas by selectively irradiating surface areas; deprotecting; contacting with receptor to identify oligonucleotide showing complementarity to receptor |
| 04/23/1996 | US5510251 Agents and method of production thereof |
| 04/18/1996 | WO1996011204A1 NOVEL β-L-NUCLEOSIDES AND THEIR USE |
| 04/18/1996 | WO1996011008A1 Administration of a 27-hydroxycholesterol or prodrug thereof as an anti-cancer agent |
| 04/17/1996 | EP0706530A1 Liponucleotides of desoxynucleosides, their preaparation and their use as anti-viral drugs |
| 04/16/1996 | US5508393 Process for the preparation of ribonucleotide reductase inhibitors |
| 04/16/1996 | US5508271 Treatment of neurological dysfunction with methylcobalamin |
| 04/16/1996 | US5508270 Nucleoside phosphinate compounds and compositions |
| 04/11/1996 | WO1996010576A1 HIGH-AFFINITY OLIGONUCLEOTIDE LIGANDS TO IMMUNOGLOBULIN E (IgE) |
| 04/11/1996 | WO1996006851A3 D-xylofuranose derivatives, method of preparing them, their use, and novel intermediate compounds for the method |
| 04/11/1996 | DE19518216A1 Neue ß-L-Nucleoside und ihre Verwendung New .beta.-L-nucleosides and their use |
| 04/10/1996 | EP0649429A4 Heteroatomic oligonucleoside linkages. |
| 04/10/1996 | EP0642526A4 Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of gdp-fucose. |
| 04/10/1996 | EP0448697B1 Vitamin a analogues and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
| 04/09/1996 | US5506352 Process for the synthesis of 9-(β-D-arabinofuranosyl)adenine, 5'-phosphate |
| 04/09/1996 | US5506351 Process for the preparation of 2'-O-alkyl guanosine and related compounds |
| 04/09/1996 | US5506349 Reacting 5'-silylated-2',3'-deoxyuridine with 2,3,4-triazole, phosphorus oxychloride and ammonia; cleaving silyl group with ion exchange resin |
| 04/09/1996 | US5506347 Lyxofuranosyl analogues of adenosine |
| 04/09/1996 | US5506262 Cholesterol lowering compounds |
| 04/09/1996 | US5506233 Desosamino derivatives of macrolides as immunosuppressants and antifungal agents |
| 04/09/1996 | US5506215 1-(3'-fluoro-2',3'-dideoxy-β-D-ribofuranosyl)-5-substituted pyrimidine nucleosides |
| 04/09/1996 | US5506214 Use of substituted adenine derivatives for treating multiple sclerosis |
| 04/09/1996 | US5506213 Adminstration of 2'-halo-2'-deoxy adenosine to treat inflammatory bowel disease |
| 04/09/1996 | US5506212 Oligonucleotides with substantially chirally pure phosphorothioate linkages |
| 04/04/1996 | WO1996010030A1 Oligomers having heteroatom-linked conjugate groups |
| 04/03/1996 | EP0704536A1 Method for the isolation and purification of nucleotid-activated sugars from biological sources |
| 04/03/1996 | CN1119869A N-alkyl-2-substituted ATP analogues |
| 04/02/1996 | US5503978 Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase |
| 04/02/1996 | US5503837 Improving the solvent extraction with solvent mixture containing a nonpolar and a polar hydrocarbon solvent |
| 03/28/1996 | WO1996009316A1 Parallel selex |
| 03/27/1996 | EP0702688A1 Antiparasitic agents |
| 03/27/1996 | EP0702683A1 06-substituted guanine derivatives, a process for their preparation and their use in treating tumour cells |
| 03/27/1996 | EP0702675A1 Method for palladium catalyzed carbon-carbon coupling and products |
| 03/27/1996 | EP0660842A4 Oligonucleotides having universal nucleoside spacers. |
| 03/27/1996 | EP0495053B1 New linker for bioactive agents |
| 03/27/1996 | EP0262125B1 AICA riboside for the prophylactic treatment of diseases with restricted blood flow. |
| 03/27/1996 | CN1119440A 2,6-diaminopurine derivatives |
| 03/27/1996 | CN1031406C High -cis-1,4-polybutadiene suitable for preparing high-impact-resisting polyphenylethylene and preparing process thereof |
| 03/27/1996 | CN1031405C Method for separation of inosine |
| 03/26/1996 | US5502177 Pyrimidine derivatives for labeled binding partners |
| 03/21/1996 | WO1996008503A1 Intermediates for dinucleotide and oligonucleotide analogues |
| 03/21/1996 | CA2198900A1 Intermediates for dinucleotide and oligonucleotide analogues |
| 03/20/1996 | EP0701564A1 Bifunctional nucleosides, oligomers thereof, and methods of making and using the same |
| 03/20/1996 | CN1031343C Process for preparation of deoxynucleosides |
| 03/14/1996 | WO1996007669A1 Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides |
| 03/14/1996 | WO1996007666A1 Mononucleotide and dinucleotide analogues and intermediates therefor |
| 03/14/1996 | WO1996007419A1 2-halo-2'-deoxyadenosine treatment for histiocytosis |
| 03/14/1996 | CA2199271A1 2-halo-2'-deoxyadenosine treatment for histiocytosis |
| 03/14/1996 | CA2197479A1 Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides |
| 03/12/1996 | US5498819 Inhibitors of phosphodiesterase as neurotropic agents, antiinflammatory agents, muscle relaxants, anticarcinogenic agents and antidiabetic agents |
| 03/12/1996 | US5498605 Sulfo-derivatives of adenosine |
| 03/12/1996 | CA1338141C Process for production of avermectins and cultures therefor |
| 03/12/1996 | CA1338140C Antibiotic agents from streptomyces cyaneogriseus noncyanogenus and method of production thereof |
| 03/07/1996 | WO1996006950A1 Reduction of nonspecific hybridization by using novel base-pairing schemes |
| 03/07/1996 | WO1996006853A1 Activated nucleoside phosphoramidites and methods for the preparation and use thereof |
| 03/07/1996 | WO1996006851A2 D-xylofuranose derivatives, method of preparing them, their use, and novel intermediate compounds for the method |
| 03/07/1996 | WO1996006620A2 Lipid analogs for treating viral infections |
| 03/07/1996 | WO1996002553A3 AMINO PURINE-β-D-RIBOFURANURONAMIDE DERIVATIVES |
| 03/07/1996 | CA2197901A1 Reduction of nonspecific hybridization by using novel base-pairing schemes |
| 03/07/1996 | CA2174216A1 Activated nucleoside phosphoramidites and methods for the preparation and use thereof |
| 03/06/1996 | EP0699204A1 Use of indolocarbazole derivatives to treat a pathological condition of the prostate |
| 03/06/1996 | CN1117969A Method for the purification of 23-E isomers of 23-imino derivatives of LL-F28249 compounds |
| 03/05/1996 | US5496938 Nucleic acid ligands to HIV-RT and HIV-1 rev |
| 03/05/1996 | US5496935 2',3'-dideoxynucleoside pyrimidine compounds and carbocyclic analogs |
| 03/05/1996 | US5496809 Of water, 8-n-(diethylaminoethyl)rebeccamycin and a pharmaceutically acceptable acid |
| 03/05/1996 | US5496727 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| 03/03/1996 | CA2157457A1 Process for isolating and purifying nucleotide-activated sugars from biological sources |
| 02/29/1996 | WO1996006105A1 Novel n-4 modified pyrimidine deoxynucleotides and oligonucleotide probes synthesized therewith |
| 02/29/1996 | WO1996006103A2 α-D-PENTOFURANOSIDE DERIVATIVES, PROCESS FOR PREPARING THE SAME AND THEIR USE |
| 02/29/1996 | WO1996005900A1 Process for the vacuum distillation of a liquid product, preferably crude petroleum, and a facility for carrying out the process |
| 02/29/1996 | DE4430401A1 D-Xylofuranose-Derivate, Verfahren zu deren Herstellung, deren Verwendung und neue Zwischenverbindungen für das Verfahren D-xylofuranose-derivatives, processes for their preparation, their use and to novel intermediate compounds for the process |
| 02/29/1996 | CA2198384A1 Alpa-d-pentofuranoside derivatives, process for preparing the same and their use |
| 02/28/1996 | EP0698611A1 Process for N-acyl-5-fluorocytidine derivatives |
| 02/28/1996 | EP0698610A1 Process for producing sialic acid derivative and novel sialic acid derivative |
| 02/28/1996 | EP0698034A1 Triester phosphorothioate oligonucleotides and method of preparation |
| 02/28/1996 | EP0698033A1 Purification of fluoronucleosides |
| 02/28/1996 | EP0698032A1 Preparation of fluoro-nucleosides and intermediates for use therein |
| 02/28/1996 | EP0550714B1 Processes for production of zidovudine |
| 02/27/1996 | US5495010 Acid stable purine dideoxynucleosides |
| 02/27/1996 | US5495009 Oligonucleotide analogs containing thioformacetal linkages |
| 02/27/1996 | US5494931 Anticoccidial in poultry, preventing and treating swine dysentery, growth promoter in cattle and swine |
| 02/27/1996 | US5494820 Streptomyces braegensis strain and its cultivation in a process for producing C9 -desoxo-FK-520 |
| 02/22/1996 | WO1996005213A1 Sequence-specific binding oligomers for nucleic acids and their use in antisense strategies |
| 02/22/1996 | WO1996004923A1 Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides |
| 02/22/1996 | DE4418691A1 3'-(4'-) nicht-radioaktiv markierte Nukleoside und Nukleotide mit Aminocarbonsäure-, Peptid- oder Carbonsäure-Spacer 3 '- (4') non-radioactively labeled nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid-spacer |
| 02/22/1996 | CA2197205A1 Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides |
| 02/22/1996 | CA2196306A1 Sequence-specific binding oligomers for nucleic acids and their use in antisense strategies |
| 02/20/1996 | US5493019 Useful as antiinflammatory and antiproliferative agents |
| 02/20/1996 | US5493012 Forming permanent covalent crosslink; in vivo probes |
| 02/20/1996 | US5492898 Method of treating endotoxin effects with 2-methylthio-ATP and analogs |